RS
Ramalingaiyar Sadhanantham
About Ramalingaiyar Sadhanantham
Data last updated:
Ramalingaiyar Sadhanantham has 19 years in corporate governance. Holds Director role. Currently with 1 company, including Deo Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Deo Pharmaceuticals Private Limited at ₹1.09 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Deo Pharmaceuticals Private Limited U24231TN2004PTC054831 | Director | 12 Jan 2007 | 2004 | ₹1.09 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramalingaiyar Sadhanantham
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramalingaiyar Sadhanantham
Ramalingaiyar Sadhanantham has 19 years in corporate governance. Holds Director role. Currently with 1 company, including Deo Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Deo Pharmaceuticals Private Limited at ₹1.09 Cr (FY 2024).
Ramalingaiyar Sadhanantham is associated with 1 company as Director, including Deo Pharmaceuticals Private Limited (₹1.09 Cr).
Ramalingaiyar Sadhanantham has expertise in General Business.
Ramalingaiyar Sadhanantham has 19 years in corporate governance.
By reported revenue, the largest current company of Ramalingaiyar Sadhanantham is Deo Pharmaceuticals Private Limited, with revenue of ₹1.09 Cr (FY 2024).
Ramalingaiyar Sadhanantham currently holds positions at 1 company: Deo Pharmaceuticals Private Limited (₹1.09 Cr).